You can buy or sell Inogen and other stocks, options, ETFs, and crypto commission-free!
Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. Read More The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
52 Week High
52 Week Low
Advertising and Marketing
The Motley FoolMay 8
Why Inogen Shares Are Plunging Today
What happened In response to reporting first-quarter results and lowering its guidance, shares of Inogen (NASDAQ:INGN), a high-growth medical device company focused on oxygen therapy, fell 24% as of 11:40 a.m. EDT on Wednesday. So what Here are the headline numbers from the quarter: Revenue grew 14% to $90.2 million. That beat the $89.6 million that Wall Street was expecting. Gross margin rose 150 basis points to 49.2%. Operating expenses rose 36% to $39.6 million. The big jump was caused by increased...
Health Care Sector Update for 05/08/2019: INGN, NVTA, MCK, JNJ, PFE, ABT, MRK, AMGN
Top Health Care Stocks: JNJ: -0.01% PFE: +0.22% ABT: Flat MRK: +0.12% AMGN: -0.39% Leading health care stocks were mixed in Wednesday's pre-market trading . Stocks moving on news include: (-) Inogen ( INGN ), which was slumping 31%. The company's Q1 sales rose 14.1% to $90.2 million from the year-ago period and topped the CapIQ mean for $89.69 million, while EPS of $0.24 missed expectations. (-) Invitae ( NVTA ) was declining more than 21% even as its net loss narrowed to $0.47 per share in Q1, as ...
Expected Aug 6, After Hours